<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Sadamura Y</submitter><pubmed_abstract>The free fatty acid receptor 1 (FFAR1) is suggested to function as a G protein-coupled receptor (GPR40) for medium-to-long-chain free fatty acids. Previous studies on the expression of FFAR1 revealed that the nigrostriatal region is one of the areas which express abundant FFAR1 mRNA/protein in the central nervous system (CNS). However, the role of FFAR1 in the CNS has been still largely unclarified. Here, we examined a possible functional role of FFAR1 in the control of extracellular concentrations of striatal monoamines and cocaine-induced locomotor activity. Microdialysis analysis revealed that the basal level of extracellular dopamine (DA) was significantly elevated, while the basal serotonin (5-HT) level tended to be reduced in the striatum of FFAR1 knockout (-/-) mice. Interestingly, local application of a FFAR1 agonist, GW9508, markedly augmented the striatal 5-HT release in FFAR1 wild-type (+/+) mice, whereas topical application of a FFAR1 antagonist, GW1100, significantly reduced the 5-HT release. However, the enhanced 5-HT release was completely lost in -/- mice. Although acute administration of cocaine enhanced the locomotor activity in both +/+ and -/- mice, the magnitude of the enhancement was significantly reduced in -/- mice. In addition, intraperitoneal injection of GW1100 significantly decreased the cocaine-induced locomotor enhancement. These results suggest that FFAR1 has a facilitatory role in striatal 5-HT release, and the evoked 5-HT release might contribute to enhance cocaine-induced locomotor activity.</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>699026</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8417570</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>FFAR1/GPR40 Contributes to the Regulation of Striatal Monoamine Releases and Facilitation of Cocaine-Induced Locomotor Activity in Mice.</pubmed_title><pmcid>PMC8417570</pmcid><pubmed_authors>Miyata A</pubmed_authors><pubmed_authors>Kambe Y</pubmed_authors><pubmed_authors>Tokuyama S</pubmed_authors><pubmed_authors>Yoshimoto K</pubmed_authors><pubmed_authors>Nakamoto K</pubmed_authors><pubmed_authors>Arita K</pubmed_authors><pubmed_authors>Mizunuma R</pubmed_authors><pubmed_authors>Oyoshi T</pubmed_authors><pubmed_authors>Sadamura Y</pubmed_authors><pubmed_authors>Hirasawa A</pubmed_authors><pubmed_authors>Kurihara T</pubmed_authors><pubmed_authors>Thapa S</pubmed_authors></additional><is_claimable>false</is_claimable><name>FFAR1/GPR40 Contributes to the Regulation of Striatal Monoamine Releases and Facilitation of Cocaine-Induced Locomotor Activity in Mice.</name><description>The free fatty acid receptor 1 (FFAR1) is suggested to function as a G protein-coupled receptor (GPR40) for medium-to-long-chain free fatty acids. Previous studies on the expression of FFAR1 revealed that the nigrostriatal region is one of the areas which express abundant FFAR1 mRNA/protein in the central nervous system (CNS). However, the role of FFAR1 in the CNS has been still largely unclarified. Here, we examined a possible functional role of FFAR1 in the control of extracellular concentrations of striatal monoamines and cocaine-induced locomotor activity. Microdialysis analysis revealed that the basal level of extracellular dopamine (DA) was significantly elevated, while the basal serotonin (5-HT) level tended to be reduced in the striatum of FFAR1 knockout (-/-) mice. Interestingly, local application of a FFAR1 agonist, GW9508, markedly augmented the striatal 5-HT release in FFAR1 wild-type (+/+) mice, whereas topical application of a FFAR1 antagonist, GW1100, significantly reduced the 5-HT release. However, the enhanced 5-HT release was completely lost in -/- mice. Although acute administration of cocaine enhanced the locomotor activity in both +/+ and -/- mice, the magnitude of the enhancement was significantly reduced in -/- mice. In addition, intraperitoneal injection of GW1100 significantly decreased the cocaine-induced locomotor enhancement. These results suggest that FFAR1 has a facilitatory role in striatal 5-HT release, and the evoked 5-HT release might contribute to enhance cocaine-induced locomotor activity.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2024-11-07T07:59:12.328Z</modification><creation>2022-02-11T10:17:44.973Z</creation></dates><accession>S-EPMC8417570</accession><cross_references><pubmed>34489696</pubmed><doi>10.3389/fphar.2021.699026</doi></cross_references></HashMap>